Blog dedicated to the continuous education in Gynecology and Endocrinology

 

Low bone mass in urban Indian women above 40 years of age: Prevalence and risk factors

Khadilkar, Anuradha; Kadam, Nidhi; Chiplonkar, Shashi; Divate, Uma; Khadilkar, Vaman

Objective: To assess the prevalence and the relative importance of risk factors for low bone mass in Indian pre and postmenopausal women. Methods: Data were collected on anthropometry and lifestyle factors in apparently healthy 80 pre- and 92 postmenopausal (40-75 yr) women. Bone mineral density was measured by dual energy x-ray absorptiometry. Fasting blood samples were analyzed for Parathyroid hormone, Vitamin D, calcium and zinc. more

Post to Twitter Post to Facebook

A Novel Regimen of Combination Transdermal Estrogen and Intermittent Vaginally Administered Progesterone for Relief of Menopausal Symptoms

Kroft, Jamie; Klostermann, Natalie; Moody, Joel; Taerk, Evan; Wolfman, Wendy

Objectives: To determine the safety and efficacy of a novel regimen of transdermal estrogen and vaginally administered progesterone for treatment of menopausal symptoms. Study Methods: A retrospective chart review was conducted of menopausal patients aged 46-65, using an estradiol patch and vaginally administered prometrium for at least one year. more

Post to Twitter Post to Facebook

TIBOLONE IN POSTMENOPAUSAL WOMEN: A REVIEW BASED ON RECENT RANDOMIZED CONTROLLED CLINICAL TRIALS

Nappi, R. (contact); Biglia, Nicoletta; Maffei, Silvia; Lello, Stefano – DGYE-2010-0145 [495437]

AIM: To critically discuss the use of Tibolone (T), in light of a series of very recent double-blind placebo (PL) controlled trials (LISA, LIFT, OPAL, THEBES, LIBERATE) conducted worldwide in a large number of postmenopausal women (PMW). METHODS: The most relevant publications on T therapy in PMW were considered with emphasis on menopausal symptoms, quality of life, sexuality, bone, cardiovascular system (CVS) and oncologic risk. more

Post to Twitter Post to Facebook

Debate – Diagnostic tools for menopausal symptoms

powered by WordPress Multibox Plugin v1.3.5

Diagnostic tools for menopausal symptoms
Chedraui Peter

powered by WordPress Multibox Plugin v1.3.5

Diagnostic tools for menopausal symptoms
Nachtigall Lila E

Post to Twitter Post to Facebook

Treatment with teriparatide in a patient with pregnancy associated osteoporosis

Boekhoff, Jelena – DGYE-2009-0210 [ID 465492]

Introduction: The decrease of BMD during a physiological pregnancy can in rare cases be intensified and lead to dramatic microarchitectural changes, which causes an increase incidence of fractures, preferably at the spine. This dramatic clinical picture is called pregnancy-associated osteoporosis. more

Post to Twitter Post to Facebook

© International Society of Gynecological Endocrinology - Privacy Policy